Siegel D, Martin T, Nooka A, Harvey RD, Vij R, Niesvizky R, Badros AZ, Jagannath S, McCulloch L, Rajangam K, Lonial S. Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies. Haematologica [Internet]. 2013Nov.1 [cited 2026Oct.30];98(11):1753-61. Available from: https://haematologica.org/article/view/6839